Skip to main content
Log in

Blood pressure control in the elderly: Can you have too much of a good thing?

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension (especially systolic hypertension) is very common in older persons. Systolic hypertension occurs because large conduit arteries become stiffer with age. Strong evidence from randomized trials suggests that treating systolic blood pressures initially higher than 160 mm Hg is extremely beneficial, and a recent trial extended this conclusion to healthy persons over 80 years of age. However, the only trial that has directly tested the use of more aggressive treatment goals (< 140 mm Hg) in the elderly did not show benefit in those older than 75. Risks of overtreating hypertension for the elderly include falls and orthostatic hypotension, and the most compromised older persons may be the most likely to experience adverse effects. Our current state of knowledge requires clinical judgment that balances the immediacy of adverse effects versus the potential but unproven benefits of treatment in deciding whether to treat the elderly more aggressively than the goals used in randomized trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. de Craen AJM, Gussekloo J, Teng YKO, et al.: Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study. BMJ 2003, 327:131–132.

    Article  PubMed  Google Scholar 

  2. Vasan RS, Larson MG, Leip EP, et al.: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291–1297.

    Article  PubMed  CAS  Google Scholar 

  3. Franklin SS, Jacobs MJ, Wong ND, et al.: Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001, 37:869–874.

    PubMed  CAS  Google Scholar 

  4. Staessen J, Fagard R, Amery A: Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials. J Hum Hypertens 1991, 5:469–474.

    PubMed  CAS  Google Scholar 

  5. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560–2572.

    Article  PubMed  CAS  Google Scholar 

  6. Aronow WS: Treatment of hypertension in the elderly. Geriatrics 2008, 63:21–25.

    PubMed  Google Scholar 

  7. O’Rourke MF, Hashimoto J: Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007, 50:1–13.

    Article  PubMed  Google Scholar 

  8. Neaton JD, Wentworth D: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992, 152:56–64.

    Article  PubMed  CAS  Google Scholar 

  9. Messerli FH: Osler’s maneuver, pseudohypertension, and true hypertension in the elderly. Am J Med 1986, 80:906–910.

    Article  PubMed  CAS  Google Scholar 

  10. Belmin J, Visintin JM, Salvatore R, et al.: Osler’s maneuver: absence of usefulness for the detection of pseudohypertension in an elderly population. Am J Med 1995, 98:42–49.

    Article  PubMed  CAS  Google Scholar 

  11. Namasivayam M, McDonnell BJ, McEniery CM, O’Rourke MF: Does wave reflection dominate age-related change in aortic blood pressure across the human life span? Hypertension 2009, 53:979–985.

    Article  PubMed  CAS  Google Scholar 

  12. Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.

    Article  PubMed  Google Scholar 

  13. Kannel WB: Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J 1999, 138:205–210.

    Article  PubMed  CAS  Google Scholar 

  14. Goodwin JS: Embracing complexity: a consideration of hypertension in the very old. J Gerontol A Biol Sci Med Sci 2003, 58:653–658.

    PubMed  Google Scholar 

  15. Alderman MH: Blood pressure J-curve: is it cause or effect? Curr Opin Nephrol Hypertens 1996, 5:209–213.

    Article  PubMed  CAS  Google Scholar 

  16. Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ: Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 1998, 316:1780–1784.

    PubMed  CAS  Google Scholar 

  17. Vatten LJ, Holmen J, Krüger O, et al.: Low blood pressure and mortality in the elderly: a 6-year follow-up of 18,022 Norwegian men and women age 65 years and older. Epidemiology 1995, 6:70–73.

    Article  PubMed  CAS  Google Scholar 

  18. Clausen J, Jensen G: Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens 1992, 6:53–59.

    PubMed  CAS  Google Scholar 

  19. Hakala SM, Tilvis RS, Strandberg TE: Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. Eur Heart J 1997, 18:1019–1023.

    PubMed  CAS  Google Scholar 

  20. Kannel WB, D’Agostino RB, Silbershatz H: Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 1997, 134:758–763.

    Article  PubMed  CAS  Google Scholar 

  21. Cruickshank JM: Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther 2000, 14:373–379.

    Article  PubMed  CAS  Google Scholar 

  22. Satish S, Freeman DHJ, Ray L, Goodwin JS: The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc 2001, 49:367–374.

    Article  PubMed  CAS  Google Scholar 

  23. Sørensen KH, Hilden T: Increased total mortality and decreased functional capacity are associated with low systolic blood pressure among elderly women. Scand J Prim Health Care 1988, 6:105–110.

    Article  PubMed  Google Scholar 

  24. Rajala S, Haavisto M, Heikinheimo R, Mattila K: Blood pressure and mortality in the very old. Lancet 1983, 2:520–521.

    Article  PubMed  CAS  Google Scholar 

  25. Glynn RJ, Field TS, Rosner B, et al.: Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995, 345:825–829.

    Article  PubMed  CAS  Google Scholar 

  26. Busby WJ, Campbell AJ, Robertson MC: Low blood pressure is not an independent determinant of survival in an elderly population. Age Ageing 1996, 25:449–452.

    Article  PubMed  CAS  Google Scholar 

  27. Mattila K, Haavisto M, Rajala S, Heikinheimo R: Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed) 1988, 296:887–889.

    Article  CAS  Google Scholar 

  28. van Bemmel T, Woittiez K, Blauw GJ, et al.: Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-Plus Study. J Am Soc Nephrol 2006, 17:2561–2566.

    Article  PubMed  Google Scholar 

  29. Rastas S, Pirttil: Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc 2006, 54:912–918.

    Article  PubMed  Google Scholar 

  30. Molander L, Lövheim H, Norman T, et al.: Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc 2008, 56:1853–1859.

    Article  PubMed  Google Scholar 

  31. Boutitie F, Gueyffier F, Pocock S, et al.: J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individualpatient data. Ann Intern Med 2002, 136:438–448.

    PubMed  Google Scholar 

  32. Le Couteur DG, Fisher AA, Davis MW, McLean AJ: Postprandial systolic blood pressure responses of older people in residential care: association with risk of falling. Gerontology 2003, 49:260–264.

    Article  PubMed  Google Scholar 

  33. Poon IO, Braun U: High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 2005, 30:173–178.

    Article  PubMed  CAS  Google Scholar 

  34. Landau K, Winterkorn JM, Mailloux LU, et al.: 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996, 114:570–575.

    PubMed  CAS  Google Scholar 

  35. Rosendorff C, Black HR: Evidence for a lower target blood pressure for people with heart disease. Curr Opin Cardiol 2009, 24:318–324.

    Article  PubMed  Google Scholar 

  36. McGuinness B, Todd S, Passmore P, Bullock R: The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006, CD004034.

  37. Birns J, Kalra L: Cognitive function and hypertension. J Hum Hypertens 2009, 23:86–96.

    Article  PubMed  CAS  Google Scholar 

  38. Poon IO: Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 2008, 28:366–375.

    Article  PubMed  CAS  Google Scholar 

  39. Insua JT, Sacks HS, Lau TS, et al.: Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994, 121:355–362.

    PubMed  CAS  Google Scholar 

  40. Izzo JLJ, Levy D, Black HR: Clinical advisory statement. Importance of systolic blood pressure in older Americans. Hypertension 2000, 35:1021–1024.

    PubMed  Google Scholar 

  41. Chaudhry SI, Krumholz HM, Foody JM: Systolic hypertension in older persons. JAMA 2004, 292:1074–1080.

    Article  PubMed  CAS  Google Scholar 

  42. JATOS Study Group: Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008, 31:2115–2127.

    Article  Google Scholar 

  43. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033–1041.

    Article  Google Scholar 

  44. Arima H, Chalmers J, Woodward M, et al.: Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006, 24:1201–1208.

    Article  PubMed  CAS  Google Scholar 

  45. Ogihara T, Saruta T, Matsuoka H, et al.: Valsartan in Elderly Isolated Systolic Hypertension (VALISH) study: rationale and design. Hypertens Res 2004, 27:657–661.

    Article  PubMed  Google Scholar 

  46. Beckett NS, Peters R, Fletcher AE, et al.: Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887–1898.

    Article  PubMed  CAS  Google Scholar 

  47. Blood Pressure Lowering Treatment Trialists’ Collaboration, Turnbull F, Neal B, et al.: Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008, 336:1121–1123.

    Article  PubMed  CAS  Google Scholar 

  48. Pedersen ME, Cockcroft JR: What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?. Curr Opin Cardiol 2009, 24:325–332.

    Article  PubMed  Google Scholar 

  49. Wiysonge CS, Bradley H, Mayosi BM, et al.: Beta-blockers for hypertension. Cochrane Database Syst Rev 2007, CD002003.

  50. Carlberg B, Samuelsson O, Lindholm LH: Atenolol in hypertension: is it a wise choice? Lancet 2004, 364:1684–1689.

    Article  PubMed  CAS  Google Scholar 

  51. Nichols WW, O’Rourke MF: Aging: a physical perspective. In Arterial Stiffness in Hypertension. Edited by Safar ME and O’Rourke MF. New York: Elsevier; 2006:379–398.

    Google Scholar 

  52. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264.

    Article  Google Scholar 

  53. Staessen JA, Fagard R, Thijs L, et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757–764.

    Article  PubMed  CAS  Google Scholar 

  54. Liu L, Wang JG, Gong L, et al.: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998, 16:1823–1829.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David J. Hyman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyman, D.J., Taffet, G.E. Blood pressure control in the elderly: Can you have too much of a good thing?. Current Science Inc 11, 337–342 (2009). https://doi.org/10.1007/s11906-009-0057-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-009-0057-y

Keywords

Navigation